ARTV vs PVH · $37.3M cap vs P/E 24, rev $8.95B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus PVH Corp (PVH) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
PVH Corp (PVH) is a apparel manufacturing company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported PVH revenue for 2026-02-01 was $8.95B. Net income was $25.3M. Revenue was up 3.4% from 2025-02-02 to 2026-02-01. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
ARTV currently screens at market cap $37.3M. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
Not investment advice. Open the ARTV and PVH stock pages for the full models.
Not investment advice.